World

Australian gov't to subsidize RSV vaccines for pregnant women, babies

Nov 10, 2024

Canberra [Australia], November 10: The Australian government has said it will make vaccination against respiratory syncytial virus (RSV) free for newborns and pregnant women from 2025.
Mark Butler, the minister for health, on Sunday announced 174.5 million Australian dollars (114.8 million U.S. dollars) in funding to subsidize RSV vaccinations following a spike in cases in 2024.
According to the government, 12,000 Australian babies are admitted to hospital every year with severe cases of RSV -- a contagious virus mostly affecting young children that causes infections of the respiratory tract.
Under the new program, women who are between 28 and 36 weeks pregnant will be eligible for a free vaccine from February, giving protection to their unborn children.
Additionally, all children younger than two years whose mothers were not immunized during pregnancy will also be eligible for free vaccination in winter when RSV infections typically occur.
The maternal RSV vaccine is currently only available in Australia to women in the late stages of pregnancy and costs up to 350 AUD (230.3 USD).
Australia has recorded over 165,000 cases of RSV so far in 2024, up from 128,117 in 2023 and 95,959 in 2022, according to data from the Department of Health's National Notifiable Disease Surveillance System.
Of the 2024 cases, 82,048 were recorded in children aged 0-4 and another 14,016 in those aged 5-9.
Source: Xinhua

More news

Artemis Hospital Partners with ABTP to Revolutionize Physiotherapy

Gurugram (Haryana) [India], November 23: Artemis Hospital, a leading healthcare provider and ABTP (Abhinav Bindra Targeting Performance), a renowned physiotherapy and rehabilitation centre, today announced the launch of the ADVANCED PHYSIO CARE CLINIC. This strategic partnership brings together the expertise of both organisations to provide world-class physiotherapy and rehabilitation services to cater to diverse patient needs in Delhi, NCR.

Nov 23, 2024